# A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

> **NCT00942175** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 160 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel and Lansoprazole
- **DRUG:** Clopidogrel and Dexlansoprazole
- **DRUG:** Clopidogrel and Omeprazole
- **DRUG:** Clopidogrel and Esomeprazole

## Key facts

- **NCT ID:** NCT00942175
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2012-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942175, "A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00942175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*